β-Amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes
- 25 April 2003
- journal article
- Published by Elsevier in Brain Research
- Vol. 970 (1-2) , 205-213
- https://doi.org/10.1016/s0006-8993(03)02344-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Amyloid-β peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide releaseBrain Research, 1998
- Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of LamininCell, 1997
- Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-β Peptide (1–40)Journal of Neuroscience, 1996
- Increased Production of Matrix Metalloproteinases in Enriched Astrocyte and Mixed Hippocampal Cultures Treated with β‐Amyloid PeptidesJournal of Neurochemistry, 1996
- Release of Biological Activities from Quiescent Fibronectin by a Conformational Change and Limited Proteolysis by Matrix MetalloproteinasesBiochemistry, 1995
- Cytokines Regulate Gelatinase A and B (Matrix Metalloproteinase 2 and 9) Activity in Cultured Rat AstrocytesJournal of Neurochemistry, 1995
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- β-Amyloid neurotoxicity: A discussion of in vitro findingsNeurobiology of Aging, 1992
- Characterization of Neutral Proteinases from Alzheimer‐Affected and Control Brain Specimens: Identification of Calcium‐Dependent Metalloproteinases from the HippocampusJournal of Neurochemistry, 1992
- Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's diseaseCell, 1988